Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 22% ± 6% | |
epithelial cell | 5 studies | 30% ± 11% | |
oligodendrocyte | 5 studies | 20% ± 3% | |
squamous epithelial cell | 3 studies | 30% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4691.78 | 258 / 258 | 100% | 42.61 | 230 / 230 |
esophagus | 100% | 5341.10 | 1445 / 1445 | 100% | 29.69 | 183 / 183 |
ovary | 100% | 5510.43 | 180 / 180 | 100% | 27.76 | 430 / 430 |
pancreas | 100% | 3484.52 | 328 / 328 | 100% | 31.39 | 178 / 178 |
thymus | 100% | 5745.58 | 653 / 653 | 100% | 45.47 | 605 / 605 |
uterus | 100% | 5375.19 | 170 / 170 | 100% | 44.95 | 459 / 459 |
brain | 100% | 6039.39 | 2640 / 2642 | 100% | 69.64 | 705 / 705 |
liver | 100% | 4136.50 | 226 / 226 | 100% | 28.34 | 405 / 406 |
stomach | 100% | 4111.82 | 359 / 359 | 100% | 36.30 | 285 / 286 |
intestine | 100% | 5045.39 | 966 / 966 | 99% | 40.56 | 524 / 527 |
prostate | 100% | 5915.71 | 245 / 245 | 99% | 44.44 | 499 / 502 |
kidney | 100% | 5316.91 | 89 / 89 | 99% | 34.36 | 895 / 901 |
skin | 100% | 4401.69 | 1808 / 1809 | 99% | 50.02 | 469 / 472 |
breast | 100% | 4616.73 | 459 / 459 | 99% | 37.23 | 1107 / 1118 |
bladder | 100% | 4808.86 | 21 / 21 | 99% | 39.71 | 499 / 504 |
lung | 100% | 4309.07 | 577 / 578 | 99% | 31.64 | 1143 / 1155 |
adipose | 100% | 4172.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 49.66 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 45.13 | 29 / 29 |
muscle | 100% | 6874.66 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5405.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 42.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.15 | 1 / 1 |
blood vessel | 100% | 4151.35 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 5872.95 | 860 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2999.49 | 888 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006620 | Biological process | post-translational protein targeting to endoplasmic reticulum membrane |
GO_1904294 | Biological process | positive regulation of ERAD pathway |
GO_2000060 | Biological process | positive regulation of ubiquitin-dependent protein catabolic process |
GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
GO_0071816 | Biological process | tail-anchored membrane protein insertion into ER membrane |
GO_0036503 | Biological process | ERAD pathway |
GO_1904293 | Biological process | negative regulation of ERAD pathway |
GO_0072380 | Cellular component | TRC complex |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1904288 | Molecular function | BAT3 complex binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0060090 | Molecular function | molecular adaptor activity |
Gene name | SGTA |
Protein name | Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP) Small glutamine rich tetratricopeptide repeat co-chaperone alpha |
Synonyms | SGT SGT1 |
Description | FUNCTION: Co-chaperone that binds misfolded and hydrophobic patches-containing client proteins in the cytosol. Mediates their targeting to the endoplasmic reticulum but also regulates their sorting to the proteasome when targeting fails . Functions in tail-anchored/type II transmembrane proteins membrane insertion constituting with ASNA1 and the BAG6 complex a targeting module . Functions upstream of the BAG6 complex and ASNA1, binding more rapidly the transmembrane domain of newly synthesized proteins . It is also involved in the regulation of the endoplasmic reticulum-associated misfolded protein catabolic process via its interaction with BAG6: collaborates with the BAG6 complex to maintain hydrophobic substrates in non-ubiquitinated states . Competes with RNF126 for interaction with BAG6, preventing the ubiquitination of client proteins associated with the BAG6 complex . Binds directly to HSC70 and HSP70 and regulates their ATPase activity . .; FUNCTION: (Microbial infection) In case of infection by polyomavirus, involved in the virus endoplasmic reticulum membrane penetration and infection via interaction with DNAJB12, DNAJB14 and HSPA8/Hsc70 . . |
Accessions | K7ERW5 O43765 A0A7I2V697 A0A7I2V2U2 A0A7I2YQY5 ENST00000589251.5 ENST00000221566.7 ENST00000677149.1 A0A7I2V588 ENST00000677562.1 ENST00000587866.1 A0A7I2V4T9 ENST00000678595.1 ENST00000679138.1 ENST00000677754.1 ENST00000676984.1 ENST00000678109.1 K7EMD6 ENST00000676943.1 A0A7I2V5Z3 |